Refine by
Neurorehabilitation Articles & Analysis
12 news found
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in Institut Guttmann (Spain) and Heidelberg University Hospital (Germany), ...
Rüdiger Rupp is the Head of Experimental Neurorehabilitation at the Heidelberg University Hospital in Germany. Throughout his extensive career, he has authored over 130 publications and over 300 lectures and posters. ...
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design. Under the agreement, Iktos generative ...
ByIktos
The agreement situates AMS as BioXtreme’s representative in the Czech Republic and Slovakia, with exclusive distribution rights for BioXtreme’s neurorehabilitation products and forming connections with hospitals and rehabilitation centres around the two countries. ...
BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. The STEPS Neurorehabilitation Centre in Budapest is the first Hungarian based rehabilitation centre to use robot-assisted and robot- based gait therapy methods. ...
Villa Beretta Rehabilitation Center and BioXtreme are proud to announce that they have agreed to conduct a joint evaluation project in the hospital’s facility in Costa-Masnaga, Italy. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Villa ...
The first phase of the partnership will focus on the VR and AR environments of deXtreme™ and user interface, and will include a mutual development of new AR/VR products and games to be used by stroke patients during their neurorehabilitation therapy with our robotic system. The second phase will include integration of Jamzone’s innovative bio-sensor feedback system ...
We are proud to announce that BioXtreme was awarded a R&D grant from the Israel Innovation Authority (coupled with additional investment from our strategic investor) in the amount of $1M. The grant will be used to further develop and improve our groundbreaking solution, deXtreme, as well as develop a future finger grip product (either as a complementary product for deXtreme or an autonomous ...
Vibramoov offers a unique neurorehabilitation therapy by maintaining the functional interaction between mouvement and proprioception throughout the recovery process. ...
Stroke affects more than 15 million people worldwide. Direct access to clinically proven therapies and a full recovery is out of reach for most survivors leading to a lifetime of impairment. "Our mission is to deliver neuro-rehab in every home through robotic exoskeletons guided by AI. Latin for 'movement anewed', Motus Nova envisions a world where survivors of stroke live without impairment. We ...
Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used by people who have suffered a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis. Rex Bionics has worked with physiotherapists to develop the ...
Other journals experiencing strong Impact Factor growth include: Biorheology (23%), Cancer Biomarkers (22%), International Journal of Applied Electromagnetics and Mechanics (92%), Journal of Back and Musculoskeletal Rehabilitation (70%), Journal of Vestibular Research (46%), Journal of X-Ray Science and Technology (34%) and NeuroRehabilitation (23%). “We are extremely ...